Agere’s technology provides pre-formulation, formulation, and development solutions for promising chemical matter that has limited water solubility. The technology combines proprietary physical, analytical, and organic chemistry approaches with industry-standard, off-the-shelf processing techniques and USP/NF approved excipients to maximize in vivo performance. Formulations developed using Agere’s technology are amenable to a wide variety of oral and parenteral dosage forms.
Predictability is the cornerstone of Agere’s technology and is achieved using
novel mechanistic computational and analytical methods. Agere’s predictive
approach enables low-risk, rapid progression from discovery, to first-in-animal
studies, to the clinic, and ultimately to commercialization. Thus, customers engage
Agere at all stages of the drug discovery and development process.